oncology innovation

Market Access

New policies are shaping the market access landscape, such as the introduction of the EU HTA for oncology medicines.

News

Ipsen has agreed to buy cancer biotech Kartos Therapeutics for $450m upfront, adding a late-stage drug in the challenging MDM2 inhibitor class.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.